RxDoctor Payments Data

Audrey Baker

Family · New Lexington, OHNPI 1598296972

Payments from drug & device makers

$7,833in general payments, 2019–2025

Across 579 payments — averaging $13.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$783
  • Lilly USA, LLC$711
  • AstraZeneca$456
  • Currax Pharmaceuticals LLC$398
  • Merck$362
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$7,77499%
  • Education$601%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,833 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$16,317
Medicare patients
63
Services billed
289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin37$35,426
TrulicityDulaglutide23$29,917
OzempicSemaglutide15$21,076
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$17,489
EliquisApixaban17$15,612
MounjaroTirzepatide13$13,780
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,725
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,330
BelsomraSuvorexant12$5,461
Duloxetine Hcl66$2,461
Albuterol Sulfate HfaAlbuterol Sulfate67$1,644
Gabapentin136$1,482
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,436
Ventolin HfaAlbuterol Sulfate26$1,419
Atorvastatin Calcium204$1,162

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$711$43,69636 claims
Boehringer IngelheimJardiance$331$35,42637 claims
Novo NordiskOzempic$208$21,07615 claims
AstraZenecaBreztri Aerosphere$456$17,48928 claims
GSKTrelegy Ellipta, Anoro Ellipta$153$16,05529 claims
PfizerEliquis$313$15,61217 claims
MerckBelsomra$362$5,46112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.

Other family in New Lexington

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →